Skip to Content
Merck
  • Comparison of respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anaesthesia in spontaneously breathing ponies Part I: blood gas analysis and cardiorespiratory variables.

Comparison of respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anaesthesia in spontaneously breathing ponies Part I: blood gas analysis and cardiorespiratory variables.

Veterinary anaesthesia and analgesia (2014-08-08)
Barbara Steblaj, Stijn Schauvliege, Kiriaki Pavlidou, Frank Gasthuys, Ioannis Savvas, Luc Duchateau, Lidia Kowalczyk, Lidia Kowalczk, Yves Moens
ABSTRACT

To compare pulmonary function and gas exchange in ponies during maintenance of anaesthesia with isoflurane or by a total intravenous anaesthesia (TIVA) technique. Experimental, cross-over study. Six healthy ponies weighing mean 286 (range 233-388) ± SD 61 kg, age 13 (9-16) ± 3 years. The ponies were anaesthetized twice, a minimum of two weeks apart. Following sedation with romifidine [80 μg kg(-1) intravenously (IV)], anaesthesia was induced IV with midazolam (0.06 mg kg(-1)) and ketamine (2.5 mg kg(-1), then maintained either with inhaled isoflurane (Fe'Iso = 1.1 vol%) (T-ISO) or an IV infusion of romifidine (120 μg kg(-1) hour(-1)), midazolam (0.09 mg kg(-1) hour(-1) IV) and ketamine (3.3 mg kg(-1) hour(-1)) (T-TIVA). Ponies were placed in lateral recumbency. Breathing was spontaneous and Fi'O(2) 60%. After an instrumentation/stabilisation period of 30 minutes, arterial and mixed venous blood samples were taken simultaneously every 10 minutes for 60 minutes and analysed immediately. Oxygen extraction ratio (O(2)ER) and venous admixture were calculated. Tidal volume (TV), minute volume (MV), respiratory rate (f(R)), packed cell volume (PCV), arterial blood pressure and heart rate (HR) were measured and recorded. Data were analysed with mixed model anova (α = 0.05). Treatments were compared overall and at two selected time points (T30 and T60) using Bonferroni correction. Arterial and mixed venous partial pressures of O(2) and CO(2), and TV were significantly lower and MV and f(R) were higher in T-TIVA compared to T-ISO. Venous admixture did not differ between treatments. O(2) R was significantly higher in T-TIVA. Mean arterial pressure was higher and HR was lower in T-TIVA compared to T-ISO. Whilst arterial CO(2) was within an acceptable range during both protocols, the impairment of oxygenation was more pronounced with the T-TIVA evidenced by lower arterial and venous oxygen partial pressures.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lidocaine, analytical standard
Sigma-Aldrich
Lidocaine, powder
Supelco
Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Lidocaine, United States Pharmacopeia (USP) Reference Standard
Lidocaine, European Pharmacopoeia (EP) Reference Standard